As Chief Executive and Chief Scientific Officer of DPX Technologies, Dr. Brewer leads a biotechnology company focused on providing creative solutions for complex sample preparation.
Dr. Brewer originated the idea for a solid-phase extraction device while working for the S.C. Law Enforcement Division as a forensic toxicologist. His goal was to streamline sample preparation by transferring liquid samples and performing extractions within a pipette tip. Dr. Brewer obtained a patent for a “Disposable Pipette Extraction” (DPX) device in 2000. This flagship technology has since been rebranded as Dispersive Pipette XTRaction.
Prior to forming DPX Laboratories in 2007, Dr. Brewer worked for Clemson Veterinary Diagnostic Division as a veterinary toxicologist and served 12+ years as a chemistry instructor and research associate at the University of South Carolina.